Pharmacovigilance – News and Features

Company licenses intellectual property relating to genetic testing for warfarin response.

Validated library of monoclonal antibodies is a major step toward personalized chemotherapy management.

Collaboration to establish optimal protocols for isolating cord blood cells.

The study was intended to test the limits of RNAi expression with respect to safety and efficacy.

Studies demonstrated that injecting stem cells into the urethral muscles increases leak point pressure.

If RNAi is going to be viable as a therapy for organ-wide diseases such as hepatitis B or C, it will have to stick around.

This trial is important because it is one of the first to examine a methodology for personalizing cancer treatment.

Researchers find a way to kill cancer stem cells without harming the normal stem cells in the same tissue.

AstraZeneca will have non-exclusive access to physicochemical, pharmacological and clinical data on BioPrint® compounds.

Use of a mouse genetic analysis method may lead to a better understanding of how drugs are metabolized.